首页> Cancer chemotherapy and pharmacology> Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

导出原文传递

翻译打印收藏纠错

第一作者： Elena,Mazza

第一单位： Medical Oncology Unit, Department of Oncology, IRCCS Ospedale, San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy.

作者： Elena,Mazza ^[1] ; Alba,Brandes ^[2] ; Silvia,Zanon ^[1] ; Marika,Eoli ^[3] ; Giuseppe,Lombardi ^[4] ; Marina,Faedi ^[5] ; Enrico,Franceschi ^[2] ; Michele,Reni ^[6]

作者单位： Medical Oncology Unit, Department of Oncology, IRCCS Ospedale, San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy. ^[1] Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna - IRCCS Institute of Neurological Sciences, Bologna, Italy. ^[2] Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Besta, Milan, Italy. ^[3] Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy. ^[4] Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. ^[5] Medical Oncology Unit, Department of Oncology, IRCCS Ospedale, San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy. reni.michele@hsr.it. ^[6]

关键词 Hydroxyurea Imatinib Meningioma Salvage therapy Target therapy